The global oncologic cancers testing market is exhibiting significant expansion, propelled by a rising prevalence of myeloma and other related diseases. Experts estimate the current market value to be substantial, with projections indicating a steady compound annual growth rate (CAGR) over the coming period. Key trends shaping the industry include